SCHEMBL17049752

SCHEMBL17049752

CC1(C)Oc2cc(O)ccc2C(=O)C1Br

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.51
ALDH1A1 P00352 1/20 0.51
ESR2 Q92731 3/20 0.42
ESR1 P03372 3/20 0.42
MAPT P10636 2/20 0.41
MAOA P21397 3/20 0.41
MAOB P27338 3/20 0.41
HTR2C P28335 1/20 0.39
IDO1 P14902 2/20 0.37
CYP19A1 P11511 3/20 0.36
TUBB4A P04350 1/20 0.36
TUBB P07437 1/20 0.36
YES1 P07947 1/20 0.36
TUBA3C P0DPH7 1/20 0.36
TUBA1B P68363 1/20 0.36
TUBA4A P68366 1/20 0.36
TUBB4B P68371 1/20 0.36
TUBB3 Q13509 1/20 0.36
TUBB2A Q13885 1/20 0.36
TUBB8 Q3ZCM7 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30836878 0.79 KDM4E (0.42) KDM4EALDH1A1ESR2ESR1MAPT
SCHEMBL27212249 0.77 ALDH1A1 (0.43) KDM4EALDH1A1MAPTMAOAHTR2C
SCHEMBL6017369 0.77 IDO1 (0.41) ALDH1A1MAPTMAOBIDO1CYP19A1
SCHEMBL27212189 0.75 NR3C2 (0.42) ALDH1A1HPGD
SCHEMBL10859037 0.74 ALOX15 (0.38) KDM4EALDH1A1MAPTHPGDHTT
SCHEMBL30836916 0.73 MAOB (0.32) KDM4EALDH1A1MAOBCYP19A1HTT
SCHEMBL30836902 0.73 KDM4E (0.31) KDM4EALDH1A1
SCHEMBL1314145 0.70 ALDH1A1 (0.57) KDM4EALDH1A1ESR2ESR1MAPT
SCHEMBL30608424 0.70 ALDH1A1 (0.57) KDM4EALDH1A1ESR2ESR1MAPT
SCHEMBL4565328 0.68 ESR1 (0.55) KDM4EALDH1A1ESR2ESR1MAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250042911-A1 NOVEL BENZOPYRAN DERIVATIVE AND USE THEREOF SPARK BIOPHARMA, INC. (KR) 2025-02-06 US disclosed
EP-4365175-A1 NOVEL BENZOPYRAN DERIVATIVE AND USE THEREOF Spark Biopharma, Inc. (KR) 2024-05-08 EP disclosed
CN-117897386-A Benzopyran derivatives and uses thereof 斯帕克生物制药有限公司 2024-04-16 CN disclosed
US-9120814-B2 Compounds with embedded benzopyran motif for core structures and preparation method thereof SNU R&DB FOUNDATION (KR) 2015-09-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250042911-A1 NOVEL BENZOPYRAN DERIVATIVE AND USE THEREOF MYD88, MYADM, CD14 KDM4E 588/4885ALDH1A1 2146/4885ESR2 1625/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.